Actinium Pharmaceuticals, Inc.
جودة البيانات: 100%
ATNM
NYSE
Manufacturing
Chemicals
KWD 1.25
▼
KWD 0.01
(-0.79%)
6 months return
—
Momentum
Neutral
5Y revenue growth
-47.04%
النمو
Revenue Growth (5Y)
-47.04%
أقل من متوسط القطاع (1.72%)
Revenue (1Y)11.11%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-206.65%
أقل من متوسط القطاع (-54.68%)
ROIC-55.06%
Net Margin-37652.22%
Op. Margin-40274.44%
الأمان
Debt / Equity
N/A
Current Ratio7.96
Interest CoverageN/A
التقييم
PE (TTM|NTM)
-1.02 | -2.24
أعلى من متوسط القطاع (-1.49)
P/B Ratio2.52
EV/EBITDAN/A
Dividend YieldN/A
Quick Summary
Key Takeaways
Short bullets derived from reported financials—not the AI summary above.
Revenue declined -47.04% annually over 5 years
Negative free cash flow of -24.68 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 58.15%
Capital intensive — 115.56% of revenue goes to capex
Price History
الاتجاهات المالية
السعر المستهدف للمحللين
4 محللين
Buy
+360.0%
upside to target
الحالي
KWD 1.25
Consensus Target
KWD 5.75
KWD 4.00
أدنى
KWD 9.00
أعلى
التوقعات
مكرر الربحية المستقبلي
-2.24
ربحية السهم المستقبلية
-KWD 0.56
الإيرادات المقدّرة
9.70 M
مفاجآت الأرباح
EPS
Reported
Estimate
Forecast
Next: Q1 2026
·
EPS Est: -KWD 0.22
·
Rev Est: 0.0
| Q12025 | Q22025 | Q32025 | Q42025 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|
| Reported | -KWD 0.51 | -KWD 0.22 | -KWD 0.16 | -KWD 0.19 | — | — |
| Estimate | -KWD 0.28 | -KWD 0.35 | -KWD 0.32 | -KWD 0.19 | -KWD 0.22 | -KWD 0.24 |
| المفاجأة | -83.78% | +37.59% | +50.51% | -1.78% | — | — |
Growth
Rev 5Y: -47.04% · Earnings 1Y: N/A
Growth
Rev 5Y: -47.04% · Earnings 1Y: N/A| Revenue Growth (1Y) | 11.11% | Revenue Growth (3Y) | 5.41% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -47.04% | Earnings Growth (5Y) | N/A |
Profitability
ROE: -206.65% · Net Margin: -37652.22%
Profitability
ROE: -206.65% · Net Margin: -37652.22%| Revenue (TTM) | 90,000.0 | Net Income (TTM) | -33.89 M |
| ROE | -206.65% | ROA | -56.87% |
| Gross Margin | N/A | Operating Margin | -40274.44% |
| Net Margin | -37652.22% | Free Cash Flow (TTM) | -24.68 M |
| ROIC | -55.06% | FCF Growth (3Y) | N/A |
Safety
D/E: N/A · Current: 7.96
Safety
D/E: N/A · Current: 7.96| Debt / Equity | N/A | Current Ratio | 7.96 |
| Interest Coverage | N/A | Asset Turnover | 0.00 |
| Working Capital | 47.53 M | Tangible Book Value | 13.78 M |
Dividends
Yield: N/A · Payout: N/A
Dividends
Yield: N/A · Payout: N/A| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
Valuation
P/E: -1.02 · EV/EBITDA: N/A
Valuation
P/E: -1.02 · EV/EBITDA: N/A| P/E Ratio | -1.02 | Forward P/E | -2.24 |
| P/B Ratio | 2.52 | P/S Ratio | 385.22 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 3.58 | Fwd Earnings Yield | N/A |
| FCF Yield | -71.20% | ||
| Market Cap | 34.67 M | Enterprise Value | -18.72 M |
Per Share
EPS: -1.09 · FCF/Share: -0.79
Per Share
EPS: -1.09 · FCF/Share: -0.79| EPS (Diluted TTM) | -1.09 | Revenue / Share | 0.00 |
| FCF / Share | -0.79 | OCF / Share | -0.78 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
Efficiency
FCF Conv: 72.84% · CapEx/Rev: 115.56%
Efficiency
FCF Conv: 72.84% · CapEx/Rev: 115.56%| CapEx / Revenue | 115.56% | FCF Conversion | 72.84% |
| SBC-Adj. FCF | -35.20 M | Growth Momentum | 58.15 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 90,000.0 | 81,000.0 | 81,000.0 | 1.03 M | 1.14 M |
| Net Income | -33.89 M | -38.24 M | -48.82 M | -33.02 M | -24.77 M |
| EPS (Diluted) | -1.09 | -1.27 | -1.83 | -1.37 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -36.25 M | -42.12 M | -51.92 M | -34.10 M | -24.96 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 21.12 M | 30.05 M | 38.67 M | 23.14 M | 18.03 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 173,000.0 | 197,000.0 | 790,000.0 | 699,000.0 | 524,000.0 |
| Interest Expense | — | — | 3.10 M | 1.09 M | 190,000.0 |
| Income Tax | — | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 51.78 M | 76.90 M | 81.45 M | 114.19 M | 80.39 M |
| Total Liabilities | 43.94 M | 44.14 M | 45.07 M | 47.71 M | 6.84 M |
| Shareholders' Equity | 7.83 M | 32.76 M | 36.38 M | 66.48 M | 73.55 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 48.00 M | 72.90 M | 76.68 M | 108.91 M | 77.83 M |
| Current Assets | 49.38 M | 74.51 M | 78.26 M | 110.94 M | 79.75 M |
| Current Liabilities | 7.97 M | 8.15 M | 8.49 M | 10.63 M | 6.84 M |
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1605 نظير)
مقارنة بشركات مشابهة في Manufacturing
مقارنة الأقران
مقابل وسيط قطاع Manufacturing (1605 نظير) مقارنة بشركات مشابهة في Manufacturing| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -1.0 | -1.5 |
| P/B | 2.5 | 1.6 |
| ROE % | -206.7 | -54.7 |
| Net Margin % | -37652.2 | -41.5 |
| Rev Growth 5Y % | -47.0 | 1.7 |
| D/E | — | 0.3 |
ETFs Holding This Stock
ETFs Holding This Stock
BRSIX
BRSIX
0.12% weight
{"event":"ticker_viewed","properties":{"ticker":"ATNM","listing_kind":"stock","pathname":"/stocks/atnm","exchange":"NYSE","country":"US"}}